01373nas a2200265   4500000000100000008004100001260001200042653002300054653002500077653002600102653001200128653002300140653002900163100001200192700001300204700001200217700001200229700001100241245006700252856007800319300001200397490000700409520067700416022001401093       2021                            d  c10/202110aHansen’s disease10aMycobacterium leprae10aautochthonous leprosy10aleprosy10aleprosy genotyping10aleprosy in North America1 aNaidu P1 aSharma R1 aKanji J1 aMarks V1 aKing A00aAutochthonous North American Leprosy: A Second Case in Canada.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544447/pdf/idr-13-00083.pdf  a917-9230 v133 a<p>Autochthonous leprosy was reported in the Southern USA in 2011 and has comprised an average of 34% of new cases from 2015 to 2020 in that country. We report a similar case in a patient from Western Canada. A 50-year old male patient presented with a four-year history of a chronic rash. Pathology stains revealed acid-fast bacilli prompting specialist referral. Examination was suspicious for leprosy, which was confirmed on slit skin smears and molecular testing. The patient responded well to treatment. Genotypic testing mapped the organism to the 3I-2 SNP type, which is of European origin and is the type found in implicated armadillo species in North America.</p>  a2036-7430